Effect of internal biliary drainage on plasma levels of endotoxin, cytokines, and C-reactive protein in patients with obstructive jaundice

World Journal of Surgery

Volumn 26, Issue 11, 2002, Pages 1328-1332

  Padillo, Francisco J ^a   Muntane, Jordi ^a   Montero, Jose L ^a   Briceño, Javier ^a   Miño, Gonzalo ^a   Solorzano, Guillermo ^a   Sitges Serra, Antonio ^b   Pera Madrazo, Carlos ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; ENDOTOXIN; INTERLEUKIN 6; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILE DUCT PROSTHESIS; BILIARY TRACT DRAINAGE; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON BILE DUCT STONE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENDOSCOPIC SURGERY; FEMALE; GALLBLADDER TUMOR; HUMAN; LONGITUDINAL STUDY; MALE; MIRIZZI SYNDROME; OBSTRUCTIVE JAUNDICE; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SPHINCTEROTOMY; SURGICAL TECHNIQUE; VATER PAPILLA TUMOR; VATER PAPILLOTOMY; ADENOCARCINOMA; BACTERIAL INFECTION; BILIARY TRACT SURGERY; BILIARY TRACT TUMOR; BLOOD; CHOLELITHIASIS; CHOLESTASIS; ENDOSCOPY; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME; WOUND DRAINAGE;

ADENOCARCINOMA; AGED; BACTERIAL INFECTIONS; BILIARY TRACT NEOPLASMS; BILIARY TRACT SURGICAL PROCEDURES; C-REACTIVE PROTEIN; CHOLELITHIASIS; CHOLESTASIS; CYTOKINES; DRAINAGE; ENDOSCOPY; ENDOTOXINS; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NITRIC OXIDE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036835370     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-002-6232-9     Document Type: Article

References (34)

1. Bemelmans MH, Gouma DJ, Greve JW, et al. Effect of antitumour necrosis factor treatment on circulating tumour necrosis factor levels and mortality after surgery in jaundiced mice. Br. J. Surg. 1993;80:1055-1058
2. Beinle EA, Vauthey JN, Moldawer LL, et al. Hepatic tumor necrosis factor-alpha production and distant organ dysfunction in a murine model of obstructive jaundice. Am. J. Surg. 1996;171:202-206
3. Bemelmans MH, Greve JW, Gouma DJ, et al. Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factor for mortality. Gut 1996;38:447-453
4. Jiang WG, Puntis MC, Mallet MB. Neutrophil priming by cytokines in patients with obstructive jaundice. HPB Surg. 1994;7:281-289
5. Puntis MC, Jiang WG. Plasma cytokine levels and monocyte activation in patients with obstructive jaundice. J. Gastroenterol. Hepatol. 1996;11:7-13
6. Kimura F, Miyazaki M, Suwa T, et al. Serum interleukin-6 levels in patients with biliary obstruction. Hepatogastroenterology 1999;46:1613-1617
7. Haga Y, Sakamoto K, Egami H, et al. Changes in production of interleukin-1 and interleukin-2 associated with obstructive jaundice and biliary drainage in patients with gastrointestinal cancer. Surgery 1989;106:842-848
8. Falconer JS, Fearon KCH, Plester CE, et al. Cytokines, the acute-phase response and resting energy expenditure in cachectic patients with pancreatic cancer. Ann. Surg. 1994;219:325-331
9. Fearon KCH, Falconer JS, Slater C, et al. Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase response. Ann. Surg. 1998;227:249-254
10. Csendes A, Burdiles P, Maluenda F, et al. Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients With gallstones and common duct stones. Arch. Surg. 1996;131:389-394
11. Grier JF, Cohen SW, Grafton WD, et al. Acute suppurative cholangitis associated with choledocal sludge. Am. J. Gastroenterol. 1994;89:617-619
12. Falconer JS, Fearon KCH, Ross JA, et al. Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 1995;75:2077-2082
13. Espat NJ, Lopeland EM, Moldawer LL. Tumor necrosis factor and cachexia: a current perspective. Surg, Oncol. 1994;3:255-262
14. Sitges-Serra A, Franch G. Nutritional assessment. In Payne-James J, Grimble G, Silk D, editors, Artificial Nutritional Support in Clinical Practice, Sevenoaks, Kent, Edward Arnold, 1995;127-136
15. Dowidar N, Kolmos HJ, Lyon H, et al. Clogging of biliary endoprostheses: a morphologic and bacteriologic study. Scand. J. Gastroenterol. 1991;26:1137-1144
16. Van den Hazel SJ, Speelman P, Tytgat GNJ, et al. Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin. Infect. Dis. 1994;19:279-286
17. Karsten TM, Allema JH, Reinders M, et al. Preoperative biliary drainage, colonisation of bile and postoperative complications in patients with tumours of the pancreatic head: a retrospective analysis of 241 consecutive patients. Eur. J. Surg. 1996;162:881-888
18. Tomasulo PA, Levin J, Murphy PA, et al. Biological activities of tritiated endotoxins: correlation of the Limulus lysate assay with rabbit pyrogen and complement-activation assays for endotoxin. J. Lab. Clin. Med. 1977;89:308-312
19. Wachtel RF, Tsuji K. Comparison of Limulus amebocyte lysates and correlation with the United States Pharmacopeia pyrogen test. Appl. Environ. Microbial. 1977;33:1265
20. Muntané J, Montero JL, Marchal T, et al. Effect of PgE1 on TNFα status and hepatic D-galactosamine-induced apoptosis in rats. J. Gastroenterol. Hepatol. 1998;13:91-101
21. Padillo FJ, Gallardo JM, Naranjo A, et al. Changes in the pattern of visceral proteins after internal biliary drainage in patients with obstructive jaundice. Eur. J. Surg. 1999;165:550-555
22. Hatfield ARW, Terblanche J, Fataar S, et al. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled trial. Lancet 1982;2:896-899
23. McPherson GAD, Benjamin IS, Hodgson HJF, et al. Preoperative percutaneous transhepatic biliary drainage: the results of a controlled clinical trial. Br. J. Surg. 1984;71:371-375
24. Gouma DJ, Moody FG. Preoperative percutaneous biliary drainage: use or abuse. Surg. Gastroenterol. 1984;3:74-80
25. Pitt HA, Gomes AS, Lois JF, et al. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann. Surg. 1985;201:545-553
26. Sirenek KR, Levine BA. Percutaneous transhepatic cholangiography and biliary decompression. Arch. Surg. 1989;124:885-888
27. Lygidakis NJ, Van der Heyde MN, Lubbers MJ. Evaluation of pre-operative biliary drainage in the surgical management of pancreatic head carcinoma. Acta Chir. Scand. 1987;153:665-668
28. Speer AG, Russell RCG, Hatfield ARW, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987;2:57-62
29. Gallardo JM, Padillo FJ, Martín-Malo A, et al. Increased plasma levels of atrial natriuretic peptide and endocrine markers of volume depletion in patients with obstructive jaundice. Br. J. Surg. 1998;85:28-31
30. Padillo FJ, Gallardo JM, Gomez-Barbadillo J, et al. The effect of internal endoscopic biliary drainage on body compartment status in patients with obstructive jaundice. In Moreno E, Hidalgo M, editors, Proceedings Book 1999. I.H.P.B.A, Madrid, Jarpyo Eds. S.A., 1999;403-407
31. Kimura F, Hiyazaki M, Suwa T, et al. Hepatic protein synthesis and cytokines in obstructive jaundice. Nippon Shokakibyo Gakkai Zasshi 1992;89:2673-2681
32. Ballinger AB, Woolley JA, Ahmed M, et al. Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction. Gut 1998;42:555-559
33. Kimmings AN, van Deventer SJH, Obertop H, et al. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 2000;46:725-731
34. Rosen HR, Winkle PJ, Kendall BJ, et al. Biliary interleukin-6 and tumor necrosis factor-α in patients undergoing endoscopic retrograde cholangiopancreatography. Dig. Dis. Sci. 1997;42:1290-1294